Dr. Fram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Immunogen, Inc.
128 Sidney St
Cambridge, MA 02138Phone+1 617-995-4909
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1979 - 1980
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1976 - 1979
- Harvard Medical SchoolClass of 1976
Certifications & Licensure
- MA State Medical License 1979 - 2025
- RI State Medical License 1997 - 2000
- NJ State Medical License 1996 - 1997
- MD State Medical License 1993 - 1996
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 21 citationsEconomic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States.Jill A Bell, Aaron Galaznik, Eileen Farrelly, Marlo Blazer, Sharanya Murty
Leukemia Research. 2018-08-01 - 72 citationsRandomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.Mikkael A. Sekeres, Justin M. Watts, Atanas Radinoff, Montserrat Arnan Sangerman, Marco Cerrano
Leukemia. 2021-01-22 - 6 citationsTransfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care.Jill A Bell, Aaron Galaznik, Marlo Blazer, Eileen Farrelly, Augustina Ogbonnaya
Leukemia & Lymphoma. 2019-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: